Failure to eradicate intracellular *S. aureus* cannot be fully explained by poor antibiotic penetration^[@R3]--[@R5]^. Phagocytes can induce antibiotic tolerance of internalized *Salmonella* Typhimurium (through vacuolar acidification, nutritional deprivation and the activation of toxin-antitoxin modules^[@R6]^), and *Mycobacterium tuberculosis* (through nitrosative stress^[@R7]^). In this study, we aimed to determine the antibiotic susceptibility of phagocytosed *S. aureus* and examine the impact of intracellular stresses on the outcome of antibiotic therapy in vitro and during a systemic infection in mice.

To assess the susceptibility of intracellular *S. aureus* to antibiotics, we incubated *S. aureus* with unstimulated J774 macrophages or macrophages that were stimulated overnight with lipopolysaccharide and interferon-𝛄 (LPS/IFNγ) to enhance their microbiocidal activity. Cells were challenged with rifampicin, a bactericidal antibiotic used in the treatment of *S. aureus* infection, which penetrates the macrophage rapidly by passive diffusion^[@R8]^. Interestingly, the majority of *S. aureus* cells that were internalized by unstimulated macrophages remained susceptible to rifampicin killing ([Fig. 1a](#F1){ref-type="fig"}--[b](#F1){ref-type="fig"}). In contrast, stimulated macrophages were more efficient at reducing the *S. aureus* burden, but the surviving bacteria were significantly more tolerant to rifampicin ([Fig. 1a](#F1){ref-type="fig"}--[b](#F1){ref-type="fig"}).

We hypothesized that specific stresses encountered in the phagolysosome induce antibiotic tolerance in S. *aureus.* We examined the role of phagolysosome-associated stressors in the induction of antibiotic tolerant *S. aureus* cells in vitro. We exposed an exponential phase population of *S. aureus* to a variety of reagents to emulate oxidative stress, phagosome acidification and nutrient deprivation for 20min prior to treatment with rifampicin ([Fig. 1c](#F1){ref-type="fig"}). Mupirocin mimics nutrient deprivation by inducing the stringent response; it had no effect on rifampicin susceptibility ([Fig. 1c](#F1){ref-type="fig"}). Acidification of the media to pH4.5 to emulate acidification of the phagolysosome^[@R6]^ also had no effect on rifampicin susceptibility ([Fig. 1c](#F1){ref-type="fig"}). Menadione is a redox-cycling agent which transfers electrons from NADH or NADPH to oxygen to produce superoxide and generates an oxidative stress similar to that encountered during oxidative burst in phagocytes. Remarkably, menadione treatment caused the bacteria to become completely tolerant to rifampicin ([Fig. 1c](#F1){ref-type="fig"}). Addition of menadione also induced rifampicin tolerance in the MRSA strain COL ([Extended Data Fig. 1a](#F5){ref-type="fig"}). Addition of these stresses in the absence of rifampicin did not cause bacterial cell death ([Extended Data Fig. 1b](#F5){ref-type="fig"}).

Other ROS-generating compounds, paraquat, (another redox cycling agent), and hydrogen peroxide also significantly induced antibiotic tolerance. The impact of hydrogen peroxide on tolerance was less pronounced than that of the redox cycling agents, menadione and paraquat, likely due to the rapid degradation of hydrogen peroxide by catalase. ([Extended Data Fig. 1c](#F5){ref-type="fig"}). Addition of the antioxidants N-acetyl cysteine or thiourea in the presence of menadione restored antibiotic susceptibility, ROS production and growth ([Fig. 1d](#F1){ref-type="fig"}--[e](#F1){ref-type="fig"}, [Extended Data Fig. 1d](#F5){ref-type="fig"}--[e](#F5){ref-type="fig"}). Together, these results suggest that ROS coerce *S. aureus* cells into an antibiotic tolerant state.

Next, we aimed to determine if ROS can impact killing by other classes of antibiotics in vitro and in our intracellular assays. Menadione caused a dramatic induction of antibiotic tolerance to ciprofloxacin, oxacillin and vancomycin in vitro ([Extended Data Fig. 2a](#F6){ref-type="fig"}--[c](#F6){ref-type="fig"}). In tissue culture, stimulated macrophages induced tolerance to ciprofloxacin in a manner analogous to that observed with rifampicin ([Extended Data Fig. 2d](#F6){ref-type="fig"}--[e](#F6){ref-type="fig"}). Both oxacillin and vancomycin penetrate poorly into macrophages^[@R35]^, so we did not test these antibiotics in our intracellular assays. Together, these results indicate that ROS coerce *S. aureus* into a multidrug tolerant state.

Reactive oxygen species may be growth inhibitory, which has long been associated with antibiotic tolerance^[@R9],[@R10]^. However, Lopatkin et al. recently showed that metabolic activity is more predictive of antibiotic lethality than growth rate^[@R11]^. Additionally, several studies have shown that antibiotic tolerance of bacterial populations or sub-populations of persister cells are associated with reduced respiration, ATP levels or metabolic activity^[@R12]--[@R17]^. We find that although all of the ROS-generating compounds inhibited growth, growth inhibition alone is insufficient to induce rifampicin tolerance as the protein synthesis inhibitor, chloramphenicol, inhibits growth but did not induce tolerance to rifampicin ([Extended Data Fig. 3a](#F7){ref-type="fig"}--[b](#F7){ref-type="fig"}). We therefore focused on the potential of ROS to corrupt *S. aureus* central metabolism. Indeed, we found that cultures treated with menadione displayed reduced respiration and reduced levels of intracellular ATP ([Fig. 2a](#F2){ref-type="fig"}--[c](#F2){ref-type="fig"}). These results show that ROS reduce the metabolic activity of S. *aureus.*

We aimed to decipher the mechanism of ROS-induced respiration inhibition. ROS (in the form of superoxide, hydrogen peroxide and peroxynitrite) target Fe-S cluster containing enzymes, two of which, aconitase and succinate dehydrogenase, participate in the *S. aureus* TCA cycle^[@R18]--[@R20]^. Inactivation of the TCA cycle leads to a decrease in available reducing equivalents (NADH and FADH~2~) to fuel the electron transport chain, which would lead to a reduction in respiration and intracellular ATP. We hypothesized that ROS induce antibiotic tolerance by inactivating essential TCA cycle enzymes. Using colorimetric assays, the activity of aconitase and succinate dehydrogenase were determined. Menadione decreased aconitase activity ([Fig. 2d](#F2){ref-type="fig"}) and succinate dehydrogenase activity ([Extended Data Fig. 4a](#F8){ref-type="fig"}), while another TCA cycle enzyme, isocitrate dehydrogenase, which does not contain Fe-S clusters was highly active in the presence of menadione ([Extended Data Fig. 4b](#F8){ref-type="fig"}). Menadione did not significantly affect transcription of *acn* or *sdh* ([Extended Data Fig. 4c](#F8){ref-type="fig"}), confirming that menadione affects aconitase and succinate dehydrogenase at the protein level. Paraquat and hydrogen peroxide also caused a significant reduction in aconitase activity ([Extended Data Fig. 4d](#F8){ref-type="fig"}), while only paraquat and not hydrogen peroxide reduced succinate dehydrogenase activity ([Extended Data Fig. 4e](#F8){ref-type="fig"}) indicating that aconitase is likely more sensitive to ROS than succinate dehydrogenase. Importantly, isocitrate dehydrogenase was unaffected by either paraquat or hydrogen peroxide ([Extended Data Fig. 4f](#F8){ref-type="fig"}). Both aconitase activity and ATP levels in menadione treated cultures were complemented by the antioxidant N-acetyl cysteine ([Extended Data Fig. 4g](#F8){ref-type="fig"}--[h](#F8){ref-type="fig"}). Together these results suggest that ROS inactivates the TCA cycle, leading to reduced respiration and ATP production, and increased antibiotic tolerance.

We predicted that addition of excess glucose would circumvent the TCA cycle and restore antibiotic susceptibility to menadione treated cultures by generating ATP through substrate level phosphorylation. [Fig. 2e](#F2){ref-type="fig"} shows that addition of excess glucose restored rifampicin susceptibility to menadione treated cultures, and this was associated with increased ATP ([Fig. 2f](#F2){ref-type="fig"}), despite abundant ROS production and reduced aconitase activity ([Extended Data Fig. 4i](#F8){ref-type="fig"}--[j](#F8){ref-type="fig"}). These results further substantiate that ROS-induced antibiotic tolerance is associated with collapse of the TCA cycle and associated ATP depletion.

As ROS is capable of inducing antibiotic tolerance in vitro, we aimed to determine if blocking ROS production by macrophages would restore antibiotic susceptibility of phagocytosed *S. aureus* cells. Addition of the antioxidant butylated hydroxanisole (BHA) or the Phox inhibitor VAS2870 (VAS) to the stimulated J774 macrophages restored rifampicin susceptibility of intracellular *S. aureus* ([Fig. 3a](#F3){ref-type="fig"}--[b](#F3){ref-type="fig"}) and this corresponded to ROS production ([Fig. 3c](#F3){ref-type="fig"}). To confirm that these findings were not isolated to J774 macrophages, we infected human THP-1 monocyte derived-macrophages with S. *aureus. S. aureus* cells internalized by THP-1 macrophages were more susceptible to rifampicin killing in the presence of BHA, which correlated with decreased ROS production ([Extended Data Fig. 5a](#F9){ref-type="fig"}--[c](#F9){ref-type="fig"}). Together these data support our findings that macrophage-produced ROS coerce *S. aureus* into an antibiotic tolerant state.

Our in vitro data suggests that ROS induces antibiotic tolerance by inactivating the *S. aureus* TCA cycle. To determine if this mechanism is also responsible for the induction of tolerance in macrophages, we examined antibiotic susceptibility of *S. aureus* strains harboring mutations in TCA cycle genes *acnA* and *sdhB.* Indeed, we find that both mutants display increased antibiotic tolerance compared to the wild type strain when internalized by unstimulated J774 macrophages (where ROS is low) ([Fig. 3c](#F3){ref-type="fig"}--[d](#F3){ref-type="fig"}, [Extended Data Fig. 5d](#F9){ref-type="fig"}). In contrast, these mutants displayed comparable survival to the wild type strain when used to infect stimulated J774 macrophages (where ROS is high) ([Fig. 3c](#F3){ref-type="fig"}--[d](#F3){ref-type="fig"}, [Extended Data Fig. 5e](#F9){ref-type="fig"}). Together these results show that ROS inactivates the TCA cycle and that this is sufficient to induce antibiotic tolerance of *S. aureus* in macrophages, although we cannot rule out ROS having an additional impact on other components of central metabolism, such as the electron transport chain.

To address if ROS-induced antibiotic tolerance is relevant in vivo, we examined the outcome of antibiotic treatment of a systemic *S. aureus* infection in wild type or *Ncf1*^*−/−*^ mutant mice which lack p47^phox^ (a component of Phox) and are deficient in respiratory burst. Sepsis was induced by I.V. injection of *S. aureus* and mice were treated with rifampicin or the vehicle control at 24h post-infection (p.i.). At 48h p.i., *S. aureus* cells were enumerated from the spleen ([Fig. 4a](#F4){ref-type="fig"}--[b](#F4){ref-type="fig"}), kidneys and liver ([Extended Data Fig. 6a](#F10){ref-type="fig"}--[b](#F10){ref-type="fig"}). In the absence of respiratory burst, *S. aureus* achieved higher titers in the spleen, emphasizing the importance of ROS in controlling *S. aureus* survival and/or proliferation in this organ ([Fig. 4a](#F4){ref-type="fig"}). Interestingly, *S. aureus* cells in the spleen of *Ncf1*^*−/−*^ mice were far more susceptible to rifampicin than *S. aureus* in the spleen of wild-type mice ([Fig. 4a](#F4){ref-type="fig"}--[b](#F4){ref-type="fig"}). These results demonstrate that while respiratory burst is beneficial in controlling *S. aureus* burden, it also inhibits the bactericidal activity of antibiotics against infection.

The spleen is the largest secondary immune organ and contains large numbers of macrophages. Immunofluorescence staining suggests that *S. aureus* in the spleen 48h p.i. are associated with macrophages and not neutrophils ([Fig. 4c](#F4){ref-type="fig"}--[e](#F4){ref-type="fig"}), further suggesting that macrophages are the major reservoir of antibiotic tolerant *S. aureus* populations during sepsis. However, we cannot rule out the possibility that other cell types contribute to *S. aureus* persistence.

*S. aureus* in the kidney remained largely susceptible to killing by rifampicin suggesting a less prominent role of respiratory burst in this organ at 48h p.i. ([Extended Data Fig. 6a](#F10){ref-type="fig"}). As previously reported^[@R3]^, antibiotic tolerance was observed in the liver, however mutation of *Ncf1*^*−/−*^ did not increase antibiotic susceptibility of this population, suggesting an induction of antibiotic tolerance independent of Phox ([Extended Data Fig. 6b](#F10){ref-type="fig"}). This was somewhat surprising as *S. aureus* associates with Kupffer macrophages in the liver during sepsis^[@R3]^ and would be expected to experience ROS from phagocytic burst.

It has been recently shown that mitochondrial ROS is important for controlling *S. aureus* in the phagosome^[@R21],[@R22]^ and mutation of *Ncf1*^*−/−*^ will not impact this ROS generation. We administered tempol, a superoxide dismutase mimetic and potent ROS scavenger^[@R23]^ to the drinking water of wild type mice prior to I.V. infection with S. *aureus.* Starting at 24h p.i., mice were treated daily with rifampicin or the vehicle control. At 48h and 72h p.i., *S. aureus* was enumerated from the spleen, liver and kidneys ([Fig. 4f](#F4){ref-type="fig"}, [Extended Data Fig. 6c](#F10){ref-type="fig"}--[d](#F10){ref-type="fig"}). Interestingly, tempol treatment increased the antibiotic sensitivity of *S. aureus* in the spleen and liver ([Fig. 4f](#F4){ref-type="fig"}--[g](#F4){ref-type="fig"}, [Extended Data Fig. 6d](#F10){ref-type="fig"}) suggesting that during infection of the liver, mitochondrial derived ROS may play a more prominent role than Phox-derived ROS. Importantly, the spleens and livers of both the control and tempol treated mice had similar numbers of extracellular bacteria at 24h p.i. (when rifampicin was administered) indicating that extracellular expansion did not contribute to the improved antibiotic susceptibility in the tempol treated mice ([Extended Data Fig. 6e](#F10){ref-type="fig"}--[f](#F10){ref-type="fig"}). Together, these data further support a role for ROS in the induction of *S. aureus* antibiotic tolerance during infection.

Our results show that the host immune system coerces *S. aureus* into a metabolic state that is incompatible with the killing mechanism of most bactericidal antibiotics. We hypothesize that *S. aureus* can exploit this mechanism of ROS-induced tolerance to rapidly adapt without the need for genetic selection. Subsequently, cells repair/replace damaged enzymes to re-enter a growing state and become capable of causing a relapse in infection. We would predict that patients deficient in respiratory burst, though more susceptible to bacterial infection, may actually respond better to antibiotics. Strikingly, there is already evidence to suggest this. *S. aureus* cells were more susceptible to rifampicin when internalized within polymorphonuclear leukocytes (PMNs) isolated from patients with chronic granulomatous disease (CGD)(which have an impaired respiratory burst) compared to wild type PMNs, although the significance of this result may have been overlooked by the authors^[@R24]^. In addition, a recent study showed that Nox2-deficient mice responded better to antibiotics and had increased survival compared to wild type mice following influenza/*S. aureus* co-infection^[@R25]^. The authors attribute this to reduced oxidative stress-induced tissue damage and inflammation but our results suggest that the metabolic state of *S. aureus* in the Nox2-deficient mice may also be a contributing factor.

Previous studies examining ROS and antibiotic activities have been extremely polarized. They include studies suggesting that antibiotics kill cells through ROS generation^[@R26]^, studies challenging these findings^[@R27]^, and studies in Gram-negative bacteria suggesting that ROS can induce antibiotic tolerance in vitro^[@R28]--[@R30]^. Here we show that in the case of the major Gram-positive pathogen, S. *aureus,* ROS are inhibitory to antibiotic mediated killing and their generation by the host increases *S. aureus* antibiotic tolerance during infection.

Recent work by Lehar et al. identified a rifamycin analogue capable of killing intracellular *S. aureus*^[@R4]^. It is unclear how this rifalogue targets intracellular *S. aureus* but our work suggests that it maintains bactericidal activity in the presence of ROS. The use of antioxidants, scavengers and oxidase inhibitors to restore antibiotic susceptibility is an exciting prospect, however, the cost to immune-mediated clearance, at least in the case of sepsis, will likely complicate this approach. It will be interesting to examine the potential of immune modulators in combination with antibiotics to maximize the clearance of *S. aureus* and achieve efficient eradication in patients.

Methods {#S1}
=======

Macrophage growth and infection {#S2}
-------------------------------

J774A.1 murine macrophage-like cells (ATCC TIB-67) were cultured in Dulbecco's Modified Essential Media, high glucose (DMEM) (Gibco) supplemented with 10% fetal bovine serum (FBS) (Milipore), non-essential amino acids (NEAA) (Gibco), sodium pyruvate (Gibco) and L- glutamine (Gibco) in a humidified incubator at 37°C and 5% CO~2~. For infection, macrophages were seeded at a density of 2×10^5^ per well in 24 well plates in Minimum Essential Media (MEM) (Gibco) supplemented with 10% FBS and L-glutamine. We found respiratory burst to be sensitive to the media the cells were cultured in as well as the confluency history of the cells. Cells that had become more than 90% confluent no longer reliably generated reactive species in response to S. *aureus.* To stimulate the J774A.1 cells, 500ng/ml lipopolysaccharide from *Escherichia coli* O55:B5 (Sigma) and 20ng/ml recombinant murine interferon-γ (Peprotech) (LPS/IFNγ) were added to supplemented MEM for 20h^[@R31]^.

THP-1 human monocytes were cultured in RPMI (Gibco) supplemented with 10% FBS, L- glutamine and 0.05mM 2-mercaptoethanol. To differentiate monocytes to macrophage-like cells, THP-1 cells were cultured at a density of 2×10^5^ per well in 24 well plates in supplemented RPMI with 100nM phorbol 12-myristate 13-acetate (PMA) (Sigma) for 3 days. For infection, media containing PMA was removed and cells were washed with PBS. Supplemented RPMI (without PMA) was added to cells 16 hours prior to infection.

\~5×10^6^ CFU/well *S. aureus* strain HG003 wild type or mutant strains were used to infect macrophages at a multiplicity of infection (MOI) of 25. Where indicated, cells were pre-treated with 20μM butylated hydroxanisole (BHA) (Sigma) or 10μM VAS2870 (VAS) (Cayman Chemicals) for 1h prior to infection. 24-well plates were centrifuged at 1200xg for 2min to bring bacteria into contact with the macrophages. 30min p.i., the cells were washed once with PBS. Fresh media containing 30μg/ml gentamicin (Fisher) was added to kill extracellular bacteria^[@R32]^ and 10μg/ml rifampicin (Fisher) or 40μg/ml ciprofloxacin (Acros Organics) was added to the appropriate wells. At indicated times, 200μl 0.1% Triton X-100 was added to each well for 5min at 37°C to selectively lyse the macrophages and release the bacteria. 800μl PBS was added to each well, lysates were suspended by pipetting, serially diluted in 1% NaCl and plated to enumerate surviving bacteria. % survival after rifampicin treatment was determined by comparing survivors after 4h (J774) or 6h (THP-1) rifampicin treatment to survivors of the corresponding untreated 4h/6h timepoint. Averages and standard deviations of 3 biological replicates are shown (n=3). Cell lines were obtained from UNC Lineberger Comprehensive Cancer Center's Tissue Culture Facility. We did not authenticate or test cells for mycoplasma contamination. Statistical significance was calculated using the Student's t-test (unpaired, twotailed) or One-Way ANOVA or Two-Way ANOVA with Sidak's multiple comparison test as described in the figure legends.

Antibiotic survival assays {#S3}
--------------------------

*S. aureus* strains HG003 or COL were cultured aerobically in Mueller-Hinton broth (MHB) (Oxoid) at 37°C with shaking at 225 rpm for \~16h. For cell wall acting antibiotics, stationary cultures were diluted 1:1000 in MHB and grown to \~5×10^7^ CFU/ml. For all other antibiotics, stationary cultures were diluted 1:100 in MHB and grown to \~2×10^8^ CFU/ml (HG003) or \~5×10^8^ CFU/ml (COL). An aliquot was plated to enumerate CFU (Time 0) before the addition of antibiotics. Where indicated, the culture was incubated with 80μM menadione (MD) (MP Biomedicals), 0.25μg/ml mupirocin, acid, 4mM N-acetyl cysteine (NAC), 150mM thiourea (TU), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~) or 30μg/ml chloramphenicol (Cam) for 20min prior to antibiotic challenge. In the case of acid stress, the media was acidified to pH4.5 with HCl for 20min and then neutralized to pH7 with NaOH prior to antibiotic addition. The following antibiotics were added at concentrations similar to the Cmax in humans at recommended dosing; 10μg/ml rifampicin^[@R33]^ 2.34μg/ml ciprofloxacin (Acros Organics)^[@R34]^, 50μg/ml oxacillin (Acros Organics)^[@R35]^, 50μg/ml vancomycin (MP Biomedicals)^[@R36]^. At indicated times, an aliquot was removed and washed with 1% NaCl. Cells were serially diluted and plated on tryptic soy agar (TSA) to enumerate survivors or TSA containing 10μg/ml rifampicin to enumerate rifampicin resistant mutants (rifR). rifR mutants were detected at lower levels than the antibiotic tolerant population ([Extended Data Fig. 7](#F11){ref-type="fig"}) indicating that resistance did not contribute to the tolerance phenotype. We routinely used two time points to enumerate survivors, 19h and 24h after antibiotic challenge as we previously found that, in S. *aureus,* susceptible cells are killed and a stable sub-population of survivors emerges between 16 and 24h of exposure to antibiotics^[@R12][@R37]^. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) or OneWay ANOVA with Sidak's multiple comparison test or One-Way ANOVA with Dunnett's multiple comparison test as described in the figure legends.

ROS measurement {#S4}
---------------

To measure ROS, the luminescent probe L-012 (Wako Chemical Corporation) was used. For in vitro ROS measurements, HG003 was grown to \~2×10^8^ CFU/ml in MHB. Where indicated, cells were incubated with 80μM menadione, 4mM N-acetyl cysteine (NAC) or 5.5mM glucose for 20min. 10μg/ml rifampicin was added and 100μl aliquot was removed immediately and added to the wells of a white 96 well plate containing a final concentration of 1mM L-012. Luminescence was recorded after 5min in a Biotek Synergy H1 microplate reader. Aliquots were removed at additional time points (1h, 2h, 3h and 24h) and luminescence was recorded as described above. Relative luminescence units (RLU) of menadione (or menadione + NAC/glucose) treated samples were divided by the untreated (control) samples at each time point and expressed as fold increase in ROS compared to the control. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) at each time point or Two-Way ANOVA with Sidak's multiple comparison test as described in the figure legends. For tissue culture cell assays, macrophages were seeded at 2×10^4^ cells/well in white tissue culture treated 96 well plates. J774 cells were treated with LPS/IFNγ as described above. Where indicated 20μM BHA was added for 1h prior to the addition of L-012. After incubation with BHA, the cells were washed 3x with PBS. L-012 was diluted to 150μM in Hanks Balanced Salt Solution (Gibco). Luminescence was read immediately and recorded every 2min for 1.5h in a Biotek Synergy H1 microplate reader. Data shown are from the time point of peak luminescence of the control (untreated THP-1 or LPS/IFNγ stimulated J774). Averages and standard deviations of at least 3 replicates are shown (J774 n=4), (THP-1 n=3). Statistical significance was calculated using One-Way ANOVA with Sidak's multiple comparison test or a Student's t-test (unpaired, two-tailed) as described in the figure legends.

Growth curves {#S5}
-------------

*S. aureus* strain HG003 was cultured aerobically in Mueller-Hinton broth (MHB) (Oxoid) at 37°C with shaking at 225 rpm for \~16h. Stationary cultures were diluted 1:100 in MHB and grown to \~2×10^8^ CFU/ml (HG003). Growth curves were established by CFU or OD~600~ at indicated times after the addition of stresses (80μM menadione (MD), 0.25μg/ml mupirocin, acid, 4mM N-acetyl cysteine (NAC), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~) or 30μg/ml chloramphenicol (Cam)). In the case of acid stress, the media was acidified to pH4.5 with HCl for 20min and then neutralized to pH7 with NaOH.

Oxygen consumption {#S6}
------------------

HG003 was grown to \~2×10^8^ CFU/ml in MHB and incubated with or without 80μM menadione. After 2h, cells were pelleted and concentrated 3x in MHB. The samples were vortexed vigorously and immediately added to the borosilicate glass sample vessel of an Oxygraph Plus (Hansatech Instruments). Oxygen levels were allowed to equilibrate for 30 seconds (s) at a stir speed of 5. Readings were recorded for the subsequent 300s. The linear part of the graph (the first 100s) was used to calculate the rate of oxygen consumption as follows: \[(T0 - T100)/100\] and normalized to CFU. % rate of oxygen was calculated by dividing by the rate of oxygen consumption in the control and multiplying by 100. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) as described in the figure legends.

ATP assays {#S7}
----------

HG003 was grown to \~2×10^8^ CFU/ml in MHB. Where indicated cells were exposed to 80μM menadione, 5.5mM glucose or 4mM N-acetyl cysteine (NAC). After 0.5h or 2h, ATP levels were measured in 100μl cells as described previously^[@R12]^ using a BacTiter Glo kit (Promega) according to the manufacturer's instructions. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) or One-Way ANOVA with Sidak's multiple comparison test as described in the figure legends.

Aconitase assay {#S8}
---------------

HG003 was grown to \~2×10^8^ CFU/ml in MHB and incubated with or without 80μM menadione, 4mM N-acetyl cysteine (NAC), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~) or 5.5mM glucose. After 0.5 or 2h, 2--10ml cells respectively, were pelleted and resuspended in 200--300μl assay buffer and lysed with 50μg/ml lysostaphin at 37°C for 5min. Samples were pelleted and the supernatant was assayed for aconitase activity using an Aconitase Assay Kit (Abcam) as per the manufacturer's instructions. Aconitase activity was normalized to CFU. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed), One-Way ANOVA with Sidak's multiple comparison test or One-Way ANOVA with Dunnett's multiple comparison test as described in the figure legends.

Succinate dehydrogenase assay {#S9}
-----------------------------

HG003 was grown to \~2×10^8^ CFU/ml in MHB and incubated with or without 80μM menadione, 5mM paraquat (PQ) or 120mM hydrogen peroxide (H~2~O~2~). After 2h, 2--10ml cells were pelleted and resuspended in 200μl SDH sample buffer and lysed with 50μg/ml lysostaphin at 37°C for 5min. Samples were pelleted and the supernatant was assayed for succinate dehydrogenase activity using a Succinate Dehydrogenase Activity Colorimetric Assay Kit (Sigma) as per the instructions from Biovision Incorporated. SDH activity was normalized to CFU. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) or One-Way ANOVA with Dunnett's multiple comparison test as described in the figure legends.

Isocitrate dehydrogenase assay {#S10}
------------------------------

HG003 was grown to \~2×10^8^ CFU/ml in MHB and incubated with or without 80μM menadione, 5mM paraquat (PQ) or 120mM hydrogen peroxide (H~2~O~2~). After 2h, 2.4ml cells were pelleted and resuspended in 400μl IDH assay buffer and lysed with 50μg/ml lysostaphin at 37°C for 5min. Samples were pelleted and the supernatant was assayed for isocitrate dehydrogenase activity using an Isocitrate Dehydrogenase Activity Assay kit (Sigma) as per the manufacturer's instructions. Isocitrate dehydrogenase activity was normalized to CFU. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (unpaired, two-tailed) or One-Way ANOVA with Sidak's multiple comparison test as described in the figure legends.

Strain construction {#S11}
-------------------

Transcriptional reporter plasmids were constructed by amplifying −755 to +76bp of the start codon of *acnA* ^[@R38]^, 222bp and 209bp upstream of the coding regions of *sdhC* and *icd*genes, respectively, from HG003 genomic DNA using primers flanked with *EcoRI* and *XbaI* sites and inserted upstream of *gfpuvr* into the *EcoRI* and *XbaI* sites of plasmid pALC1434^[@R39]^ to yield transcription gfp-reporter plasmids *Pacn::gfp, Psdh::gfp* and *Picd::gfp.* The HG003acnA::erm *(acnA)* and HG003sdhB::erm *(sdhB)* strains were constructed by transducing the transposon mutants from the NARSA library^[@R40]^ into HG003.

Transcriptional reporter assays {#S12}
-------------------------------

*S. aureus* strain HG003 harboring *gfp* promoter plasmids or the promoterless *gfp* plasmid pALC1434 were grown to \~2×10^8^ CFU/ml in MHB containing chloramphenicol 10μg/ml. Where indicated 80μM menadione was added. After 2h, 200μl of each culture was added to the wells of a clear bottom, black side 96-well plate and absorbance (OD~600~) and GFP fluorescence (emission 528 nm and excitation 485 nm) was measured in a Biotek Synergy H1 microplate reader. GFP values were divided by OD~600~ and then values obtained for the promoter *gfp* plasmid were subtracted. Averages and standard deviations of 3 biological replicates are shown (n=3). Statistical significance was calculated using the Student's t-test (two-tailed) as described in the figure legends.

Mouse infections {#S13}
----------------

Mice were housed in a pathogen-specific free facility: wild type (WT) C57BL/6J (Jackson \# 000664), *Ncf1^−/−^* (Jackson \# 027331). All animal protocols were approved by the Institutional Animal Care and Use Committee at the University of North Carolina at Chapel Hill and met guidelines of the US National Institutes of Health for the humane care of animals. For mouse infections, 8--10 week old female mice were infected with \~5×10^6^ CFU of *S. aureus* strain HG003 in 100μl PBS by intravenous (I.V.) injection. Where indicated, mice were treated with tempol (4-Hydroxy-TEMPO) (Sigma) at 25mM in the drinking water starting 24h prior to infection. 4% sucrose was added to tempol water to increase the volume consumed by the mice. Control groups for the tempol experiments also received drinking water with 4% sucrose. Rifampicin was dissolved in vehicle (6.25% DMSO + 12.5% PEG300) at a final concentration of 6.25mg/ml. At 24h p.i., mice were treated daily with an intraperitoneal (I.P.) injection of 100μl/25g rifampicin or vehicle. At 24h, 48h or 72h p.i., organs were homogenized, serially diluted and plated on BHI agar plates for enumeration of bacterial CFU (and BHI agar plates containing rifampicin 10μg/ml for the enumeration of rifR mutants). % rifampicin tolerant cells was determined by comparing survivors after rifampicin treatment to survivors of the vehicle treated group. To quantify extracellular bacteria, at 24h p.i., samples of homogenized livers and spleens were treated with a RPMI-based digest buffer containing 2mg/ml Collagenase V (Invitrogen), 3mM CaCl~2~, 5U/ml DNase I (Fisher), 5U/ml dispase (Sigma), 5% FBS (Millipore) and 10mM HEPES for 30min. The homogenates were then centrifuged at a low speed (300xg) to pellet host cells. Aliquots of the supernatant from the low speed spin was serially diluted and plated on BHI agar to quantify extracellular bacteria. *Ncf1^−/−^* infections: Wild type mice: vehicle n=9 and rifampicin n=9. *Ncf1^−/−^* mice: vehicle n=10 and rifampicin n=11. For tempol inhibitor experiments, at 24h p.i.: control n=4, tempol n=5, at 48h p.i. and 72h p.i., control and tempol mice: vehicle n=10 and rifampicin n=10. The mean is indicated by a horizontal line. Statistical significance was calculated using the Kruskal Wallis One-Way ANOVA or the Mann-Whitney test as described in the figure legends. Sample size was chosen based on the number of mice required to reach statistical significance using the Mann Whitney test from previous experiments using the systemic model of infection. Blinding or randomization was not necessary as all outputs (CFU/g tissue) are objective.

Histopathology {#S14}
--------------

Mice were infected as above. At 48h p.i., organs were harvested and fixed in 10% neutral buffered formalin for 72h and transferred to 70% ethanol. Fixed organs were paraffin embedded and sectioned at 5μm.

Immunofluorescence Microscopy {#S15}
-----------------------------

Sections were deparaffinized and rehydrated with the following washes: 3x xylene, 3× 100% ethanol, 2× 95% ethanol, 1× 80% ethanol, 1x water. Slides were boiled for 20min and cooled to RT in citrate buffer (pH 6) to unmask antigens. Samples were blocked with 1.5% normal goat serum in PBS for 40min. Samples were incubated with block solution (control), rat monoclonal anti-mouse F4/80 (clone BM8) (eBiosciences Cat\# 14--4801-82) (1:100) or rat monoclonal antimouse Ly6G (clone 1A8) (eBiosciences Cat\# 16--9668-82) (1:100) overnight at 4°C. Samples were washed (3x in PBS) and permeabilized with 0.5% Tween 20 in PBS for 30min to allow the *S. aureus* antibody to enter cells. Samples were washed 3x with PBS and incubated for 30min with 1.5% normal goat serum. Samples were incubated with block solution (control) or anti-*S. aureus* antibody (Abcam ab20920) (1:400) overnight at 4°C. Samples were washed 3x in PBS and incubated for 1h at RT in secondary antibodies goat anti-rat conjugated to Alexa 594 (Invitrogen Cat\# A11007) and goat anti-rabbit conjugated to Alexa 488 (Invitrogen Cat\# A32731) (both at 1:1000). Samples were washed 3x in PBS, and mounted with 1.5 coverslips over tissue sections with ProLong Diamond with DAPI (Invitrogen). All antibodies were diluted in block solution. Images were obtained on a Zeiss LSM 700 Confocal Laser Scanning Microscope using a 63X/1.4 Plan Apo Oil objective lens and Zeiss ZEN 2011 software. DeconvolutionLab2 and ImageJ were used to deconvolve the images. Representative images shown are the maximum intensity projections of the Z stack.

Rifampicin stability test {#S16}
-------------------------

We aimed to determine if rifampicin is inactivated by ROS in our in vitro ([Fig. 1c](#F1){ref-type="fig"}) and tissue culture assays ([Fig. 1a](#F1){ref-type="fig"}). Minimum inhibitory concentration (MIC) assays for rifampicin were determined using a microdilution method. \~5×10^5^ *S. aureus* strain HG003 in MHB was incubated with various concentrations of rifampicin, either from a freshly prepared stock solution or following extraction from in vitro or tissue culture antibiotic survival assays as described below. An aliquot of rifampicin-containing cultures (from [Fig. 1c](#F1){ref-type="fig"}) were collected, pelleted to remove cells and filter sterilized following 19h of exposure to *S. aureus* with or without 80μM menadione. This supernatant was used as the source of rifampicin and underwent MIC testing. Similarly, sterilized rifampicin-containing MEM from either unstimulated or LPS/IFNγ stimulated J774 cells incubated with *S. aureus* for 4h ([Fig. 1a](#F1){ref-type="fig"}) were used in MIC assays. MICs were determined following 24h incubation at 37^o^C. [Extended Data Fig. 8](#F12){ref-type="fig"} shows that in vitro after 19h, when all of the killing had occurred, rifampicin activity was reduced by 2-fold in both the control-treated and menadione-treated samples. Similarly, supernatants extracted from tissue culture experiments revealed the rifampicin MIC decreased by 6-fold in both stimulated and unstimulated J774 macrophages. This data indicates that while rifampicin activity is reduced over the course of our assays, it is not affected by ROS.

Statistical information {#S17}
-----------------------

Statistical method and sample size (n) are indicated in the methods for each experiment. Statistical analysis was performed using Excel (Microsoft) or Prism 8 (GraphPad) software. For in vivo studies, n represents the number of mice per group and statistical significance was determined using the Kruskal Wallis One-Way ANOVA with Dunn's multiple comparison test or the Mann-Whitney test. For in vitro studies, n represents the number of biological replicates and statistical significance was determined using a Student's t-test (unpaired, two-tailed), One-Way ANOVA or Two-Way ANOVA with Tukey's multiple comparison test, Sidak's multiple comparison test, Dunnett's multiple comparison test (indicated in the figure legends). Statistical significance was defined as p\<0.05. Error bars on figures show standard deviations of the mean.

Extended Data {#S18}
=============

![Induction of antibiotic tolerance by ROS.\
(a) *S. aureus* strain COL or (b-e) HG003 was grown to mid-exponential phase in vitro and exposed to 80μM menadione (MD), 0.125μg/ml mupirocin, acidified media (pH4.5), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~), 4mM N-acetyl cysteine (NAC) or 150mM thiourea (TU) for 20min and either (a, c-d) challenged with 10μg/ml rifampicin or (b) plated for cfu or (e) OD~600~ was recorded every 30min for 10h. (a-d) At indicated times, an aliquot was removed and plated on tryptic soy agar (TSA) to enumerate cfu. Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a, c) Student's t-test (unpaired, two-tailed) or (d) One-Way ANOVA with Dunnett's multiple comparison test.](nihms-1541811-f0005){#F5}

![ROS induces multidrug tolerance in *S. aureus*.\
HG003 was grown to exponential phase in vitro and exposed to 80μM menadione (MD) for 20min prior to challenge with (a) 2.34μg/ml ciprofloxacin (cip), (b) 50μg/ml oxacillin (ox) or (c) 50μg/ml vancomycin (vanc). (d) Survival of *S. aureus* cells after internalization by unstimulated J774 macrophages (unstim.) or macrophages that were stimulated overnight with LPS/IFNγ (stim.). 40μg/ml cip was added at Time 0 (dotted lines). At the indicated times, an aliquot was removed, washed and plated to enumerate survivors. (e) % Survival of *S. aureus* cells treated with ciprofloxacin for 4h compared to the untreated control (data extrapolated from d). Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a-c, e) the Student's t-test (unpaired, two-tailed) or (d) One-Way ANOVA with Sidak's multiple comparison test.](nihms-1541811-f0006){#F6}

![Growth cessation is insufficient to induce tolerance to rifampicin.\
*S. aureus* strain HG003 was grown to mid-exponential phase in vitro and exposed to 80μM menadione (MD), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~) or 30μg/ml chloramphenicol (Cam) for 20min and either (a) plated for cfu or (b) challenged with 10μg/ml rifampicin. At indicated times, an aliquot was removed and plated on tryptic soy agar (TSA) to enumerate cfu. Averages of n=3 biologically independent samples. Error bars represent standard deviation.](nihms-1541811-f0007){#F7}

![ROS decreases *S. aureus* metabolic activity.\
HG003 was grown to mid-exponential phase and treated with 80μM menadione (MD), 5mM paraquat (PQ), 120mM hydrogen peroxide (H~2~O~2~), 4mM N-acetyl cysteine (NAC) or 5.5mM glucose (gluc) for (a-f, j) 2h or (g-h) 0.5h and then assayed for (a, e) succinate dehydrogenase (SDH) activity, (b, f) isocitrate dehydrogenase (IDH) activity and (d, g, j) aconitase activity. (c) Transcriptional activity of *acn, sdh* and *icd* genes was determined using promoter-gfp reporters. (h) ATP was quantified using a BactiterGlo Cell Viability Assay. (i) At indicated times, ROS production was measured using L-012 luminescent probe and expressed as a fold-increase compared to the untreated control. RLU denotes relative luminescence units. Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a-c) Student's t-test (unpaired, two-tailed) or (d-e, j) One-Way ANOVA with Dunnett's multiple comparison test, (f-h) One-Way ANOVA with Sidak's multiple comparison test or (i) Two-Way ANOVA with Sidak's multiple comparison test.](nihms-1541811-f0008){#F8}

![Macrophage-derived ROS induces antibiotic tolerance in *S. aureus*\
(a-b) Survival of *S. aureus* strain HG003 after internalization by THP-1 macrophages. Where indicated, macrophages were pre-treated with 20μM butylated hydroxanisole (BHA) for 1h prior to the addition of bacteria. (a) 10μg/ml rifampicin (rif) was added at Time 0 (dotted lines). (b) % survival was determined by comparing survivors after 6h of rifampicin treatment to survivors of the corresponding untreated timepoint (extrapolated from a). (c) ROS production by THP-1 macrophages with or without BHA treatment was quantified using the luminescent probe L-012. RLU denotes relative luminescence units. (d-e) Survival of *S. aureus* strain HG003 (WT), HG003acnA::erm *(acnA)* and HG003sdhB::erm *(sdhB)* mutants after internalization by (d) unstimulated J774 macrophages or macrophages that were (e) pre-stimulated overnight with LPS/IFNγ. 10μg/ml rifampicin (rif) was added at Time 0 (dotted lines). Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a, d-e) One-Way ANOVA with Sidak's multiple comparison test or (b-c) Student's t-test (unpaired, two-tailed).](nihms-1541811-f0009){#F9}

![Host derived-ROS induces antibiotic tolerance in a mouse model of sepsis.\
Sepsis was induced by I.V. injection of *S. aureus* strain HG003 into (a-b) C57BL/6J wild type (WT) and *Ncf1^−/−^* mutant mice or (c-d) wild type mice treated with or without 25mM tempol. At 24h p.i., mice were treated daily with 25mg/kg rifampicin or the vehicle control. *S. aureus* cfu were enumerated from the kidney and liver at 48h p.i. or 72h p.i. The mean is indicated by a horizontal line and the limit of detection is indicated by the x-axis (a-d). (a-b) Wild type mice: vehicle/rifampicin n=9 animals, *Ncf1^−/−^* mice: vehicle n=10 / rifampicin n=11 animals. (c-d) control n=4 / tempol n=5 animals (at 24h p.i,) and control/tempol mice: vehicle/rifampicin n=10 animals (at 48h and 72h p.i.). (e-f) Extracellular bacterial numbers were enumerated in the spleen and liver of control (n=3 animals) and tempol treated (n=4 animals) mice at 24h p.i. prior to antibiotic challenge and error bars represent standard deviation. Statistical significance was determined using (a-d) Kruskal Wallis One-Way ANOVA with Dunn's multiple comparison test or the (e-f) Mann-Whitney test.](nihms-1541811-f0010){#F10}

![Resistance does not contribute to menadione-induced antibiotic tolerance.\
HG003 was grown to mid-exponential phase in vitro and exposed to 80μM menadione (MD) for 20min prior to addition of 10μg/ml rifampicin. At indicated times, an aliquot was removed and plated on tryptic soy agar (TSA) to enumerate survivors or (f) TSA containing 10μg/ml rifampicin to enumerate rifampicin resistant mutants (rifR). Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using Student's t-test (unpaired, two-tailed).](nihms-1541811-f0011){#F11}

![ROS does not inactivate rifampicin.\
At indicated times the minimum inhibitory concentration (MIC) of rifampicin (rif) was determined following exposure to ROS in the in vitro antibiotic survival assays ([Fig. 1c](#F1){ref-type="fig"}) and in tissue culture intracellular survival assays ([Fig. 1a](#F1){ref-type="fig"}).](nihms-1541811-f0012){#F12}
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![Induction of antibiotic tolerance by stimulated macrophages.\
(a) Survival of *S. aureus* cells after internalization by unstimulated J774 macrophages (unstim.) or macrophages that were stimulated overnight with LPS/IFNγ (stim.). 10μg/ml rifampicin (rif) was added at Time 0 (dotted lines). (b) % Survival of *S. aureus* cells treated with rifampicin for 4h compared to the untreated control (extrapolated from a). (c-e) *S. aureus* strain HG003 was grown to mid-exponential phase in vitro and exposed to 80μM menadione (MD), 0.125μg/ml mupirocin, acidified media (pH4.5) or 4mM N-acetyl cysteine (NAC) for 20min prior to the addition of rifampicin at Time 0. At indicated times, an aliquot was removed, (c, d) washed in 1% NaCl and plated to enumerate survivors or (e) ROS production was measured using L-012 luminescent probe and expressed as a fold-increase compared to the untreated control. RLU denotes relative luminescence units. Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a, c-d) One-Way ANOVA with Sidak's multiple comparison test or (b, e) Student's t-test (unpaired, two-tailed). See also [Extended Data Fig. 1](#F5){ref-type="fig"}.](nihms-1541811-f0001){#F1}

![ROS decreases *S. aureus* metabolic activity.\
(a-d) HG003 was grown to mid-exponential phase and treated with or without 80μM menadione (MD) for 2h. (a-b) Oxygen consumption was measured for 300s (nA denotes nanoamphere) and (b) the rate of oxygen consumption was calculated using the linear range (indicated by blue line in a), (c) intracellular ATP was measured using a BactiterGlo Cell Viability Assay, (d) aconitase activity was measured. (e-f) HG003 was grown to mid-exponential phase and exposed to MD and/or indicated concentrations of glucose. Cultures were either (e) challenged with 10μg/ml rifampicin and survivors were enumerated after 24h, (f) or ATP was quantified after 30min using a BactiterGlo Cell Viability Assay. Averages of n=3 biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (b-d) Student's t-test (unpaired, two-tailed), (e) One-Way ANOVA with Dunnett's multiple comparison test or (f) One-Way ANOVA with Sidak's multiple comparison test. See also [Extended Data Fig. 4](#F8){ref-type="fig"}.](nihms-1541811-f0002){#F2}

![Macrophage derived-ROS induces antibiotic tolerance in *S. aureus*.\
(a-b, d) Survival of *S. aureus* strain HG003 (WT), HG003acnA::erm *(acnA)* and HG003sdhB::erm *(sdhB)* mutants following internalization by unstimulated J774 macrophages (unstim.) or macrophages that were pre-stimulated overnight with LPS/IFNγ (stim.). Where indicated, macrophages were treated with 20μM butylated hydroxanisole (BHA) or 10μM VAS2870 (VAS) for 1h prior to the addition of bacteria. (a) 10μg/ml rifampicin (rif) was added at Time 0 (dotted lines). (b, d) % survival was determined by comparing survivors after 4h (J774) of rifampicin treatment to survivors to the corresponding untreated timepoint. (c) ROS production by macrophages was quantified using the luminescent probe L-012. Where indicated stimulated macrophages were pre-treated with butylated hydroxanisole (BHA) prior to the addition of L-012. RLU denotes relative luminescence units. Averages of n=3 or (n=4 for c) biologically independent samples. Error bars represent standard deviation. Statistical significance was determined using (a-c) One-Way ANOVA with Sidak's multiple comparison test or (d) Two-Way ANOVA with Tukey's multiple comparison test. See also [Extended Data Fig. 5](#F9){ref-type="fig"}.](nihms-1541811-f0003){#F3}

![Host derived ROS induce antibiotic tolerance in a mouse model of sepsis.\
Sepsis was induced by I.V. injection of *S. aureus* strain HG003 into (a-b) C57BL/6J wild type (WT) and *Ncf1^−/−^* mutant mice or (f-g) WT mice treated with or without 25mM tempol. At 24h p.i., mice were treated daily with 25mg/kg rifampicin or the vehicle control. CFU were enumerated from the spleen at 24h, 48h or 72h p.i. The mean is indicated by a horizontal line. The limit of detection is indicated by the x-axis. (a-b) Wild type mice: vehicle/rifampicin n=9 animals, *Ncf1^−/−^* mice: vehicle n=10 / rifampicin n=11 animals. (f-g) control n=4 / tempol n=5 animals (at 24h p.i,) and control/tempol mice: vehicle/rifampicin n=10 animals (at 48h and 72h p.i.). Statistical significance was determined using (a, f) Kruskal Wallis One-Way ANOVA with Dunn's multiple comparison test or (b, g) the Mann Whitney two-tailed test. Immunofluorescence microscopy of wild type mouse spleen at 48h p.i. *S. aureus* cells (green in c-e) are associated with F4/80 macrophage marker (red in c-d) and not Ly6G neutrophil marker (red in e). Scale bars represent 10μm, 5μm and 10μm in c, d and e, respectively. Microscopy results are representative of three independent experiments. See also [Extended Data Fig. 6](#F10){ref-type="fig"}.](nihms-1541811-f0004){#F4}
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